ClinicalTrials.Veeva

Menu

Levels of Circulating T Cells Expressing VLA-1 Collagen Receptors

S

Sheba Medical Center

Status

Completed

Conditions

Ischemic Heart Disease

Study type

Observational

Funder types

Other

Identifiers

NCT00708838
SHEBA-02-2707-AA-CTIL

Details and patient eligibility

About

The examination of the percentage of peripheral T cells carrying VLA-1 in ischemic heart disease patients. The hypothesis is that the percentage levels of cells carrying this integrin rise according to the severity of the ischemic heart disease.

Full description

Atherosclerosis is considered an inflammatory disease in which lymphocytes have an important role. The study was disigned to find out the changes in T cell levels carrying VLA-1 involvement in this process.

Enrollment

151 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • clinical diagnosis of acute MI for group 1
  • clinical diagnosis of ACSl for group 2
  • clinical diagnosis of Chronic Heart Disease for groups 3 and 4
  • Chest pain but normal heart scan for group 5

Exclusion criteria

  • none

Trial design

151 participants in 5 patient groups

1
2
3
4
5

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems